Head to Head Contrast: PhotoMedex (PHMD) & Edap Tms (EDAP)

PhotoMedex (NASDAQ: PHMD) and Edap Tms (NASDAQ:EDAP) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitabiliy.

Institutional & Insider Ownership

5.2% of PhotoMedex shares are owned by institutional investors. Comparatively, 8.0% of Edap Tms shares are owned by institutional investors. 22.4% of PhotoMedex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares PhotoMedex and Edap Tms’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	EBITDA	Earnings Per Share	Price/Earnings Ratio
PhotoMedex	$30.70 million	0.11	-$1.42 million	N/A	N/A
Edap Tms	$40.74 million	2.36	$242,981.00	$0.15	22.13

Edap Tms has higher revenue and earnings than PhotoMedex.

Profitability

This table compares PhotoMedex and Edap Tms’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PhotoMedex	-52.25%	N/A	-45.55%
Edap Tms	11.95%	27.90%	14.60%

Risk & Volatility

PhotoMedex has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for PhotoMedex and Edap Tms, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PhotoMedex	0	0	0	0	N/A
Edap Tms	0	0	1	0	3.00

Edap Tms has a consensus target price of $7.00, suggesting a potential upside of 110.91%. Given Edap Tms’ higher probable upside, analysts plainly believe Edap Tms is more favorable than PhotoMedex.

Summary

Edap Tms beats PhotoMedex on 10 of the 11 factors compared between the two stocks.

About PhotoMedex

PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.

About Edap Tms

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.